EGFR and non-small cell lung carcinoma: However, no correlation has been so far demonstrated between the levels of CD8+ tumor infiltrating lymphocytes and sensitivity to immunotherapy in NSCLC patients with uncommon EGFR mutations, which could be warranted in future correlative studies.